- #270 ‒ Journal club with Andrew Huberman: metformin as a geroprotective drug, the power of belief, and how to read scientific papers — The Drive
In this episode, Peter Attia and Andrew Huberman hold a journal club. They discuss metformin's potential as a geroprotective drug and the influence of belief on biological effects. They also share their methodologies for interpreting resea…
- #246 - AMA #45: Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent — The Drive
This episode of The Drive podcast explores the pros and cons of GLP-1 weight loss drugs, including semaglutide and tirzepatide. It also examines the use of metformin as a potential geroprotective agent, reviewing data and Peter Attia's per…